霍乱监测与疾病负担估算
患者诊断和霍乱监测通常基于急性水样腹泻(AWD)的临床检查,并通过培养或聚合酶链反应检测确认。快速诊断检测(RDT)在实验室能力有限的地区使用,但性能差异大,敏感性为58%至100%,特异性为60%至100%。
要点
- RDT敏感性58%至100%,特异性60%至100%,性能差异大。
- 病例定义差异、不愿报告和监测不足导致负担数据被低估。
核心结论
- 霍乱仍是一个被低估和漏报的问题,需要加强全球监测和报告系统。
研究设计与样本
- 本文为综述,基于文献和建模研究讨论霍乱监测与负担估算。
主要发现
- RDT敏感性58%至100%,特异性60%至100%。
- 大多数国家依赖医院腹泻病监测计算霍乱负担。
关键数值与推荐
- WHO建议各国根据《国际卫生条例(2005)》标准评估霍乱公共卫生事件,并使用标准病例定义确定是否需要正式通报。
临床怎么用
- 应补充文献综述和建模研究的估计值来加强监测数据,开发性能更好的RDT,并加强国家监测系统的监测与评估。
- 鼓励各国通过提供技术支持和改善疫苗可及性来奖励更好的报告。
局限性
- 病例定义差异、当局不愿承认和报告霍乱、医院监测系统不足、缺乏有效诊断检测以及霍乱与其他AWD病因的临床相似性导致负担数据存在缺口。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cholera continues to be poorly controlled in multiple epidemic and endemic areas across the globe, with estimated annual incidence of 1.3-4.0 million cases, resulting in 21,000 to 143,000 deaths worldwide in 2015. The usual approach for patient diagnosis and cholera surveillance is clinical examination of cases of acute watery diarrhea (AWD), confirmed by positive culture or polymerase chain reaction tests. Rapid diagnostic tests (RDTs) are used in regions with limited laboratory capacities but have been found to demonstrate large variations in performance, ranging in sensitivity from 58% to 100% and in specificity from 60% to 100%. Most countries rely on hospital-based surveillance of diarrheal disease to compute the cholera burden. The World Health Organization (WHO) recommends that countries assess public health events involving cholera against the International Health Regulations 2005 criteria and determine need for official notification using the standard case definition. Cholera is an often under-recognized and under reported problem because of differences in case definitions, reluctance by authorities to acknowledge and report cholera, inadequacies in hospital surveillance systems, lack of effective diagnostic tests and commonalities in clinical presentation of cholera with other AWD etiologies. The resulting gap in burden data impairs economic analysis of disease impact and identification of areas for targeted control interventions. There is an urgent need to strengthen surveillance data by supplementing reported numbers with estimates from literature reviews and data from modelling studies, developing better-performing RDTs, enhancing monitoring and evaluation processes of in-country surveillance systems, and encouraging countries to report cholera cases by "rewarding" better reporting with technical support and improved access to vaccines. It is imperative that immediate steps are taken towards strengthening surveillance and reporting systems globally, especially in cholera-prone and resource-limited areas, where it will enable countries to articulate their demand for resources more accurately.
引用
- Ganesan D, Gupta SS, Legros D, et al. Cholera surveillance and estimation of burden of cholera. Vaccine. 2019. PMID: 31326254. doi:10.1016/j.vaccine.2019.07.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。